All Cosmos Bio-Tech Holding (TPE:4148) EBIT : NT$259 Mil (TTM As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is All Cosmos Bio-Tech Holding EBIT?

All Cosmos Bio-Tech Holding's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2024 was NT$55 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2024 was NT$259 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. All Cosmos Bio-Tech Holding's annualized ROC % for the quarter that ended in Dec. 2024 was 4.80%. All Cosmos Bio-Tech Holding's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 10.05%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. All Cosmos Bio-Tech Holding's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2024 was 11.27%.

All Cosmos Bio-Tech Holding EBIT Historical Data

The historical data trend for All Cosmos Bio-Tech Holding's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

All Cosmos Bio-Tech Holding EBIT Chart

All Cosmos Bio-Tech Holding Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

EBIT

Get a 7-Day Free Trial

154.11

326.12

652.76

261.61

258.85

All Cosmos Bio-Tech Holding Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
EBIT	Get a 7-Day Free Trial															24.16	56.95	29.44	117.70	54.76

Competitive Comparison of All Cosmos Bio-Tech Holding's EBIT

For the Agricultural Inputs subindustry, All Cosmos Bio-Tech Holding's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

All Cosmos Bio-Tech Holding's EV-to-EBIT Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, All Cosmos Bio-Tech Holding's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where All Cosmos Bio-Tech Holding's EV-to-EBIT falls into.

Save Embed

;

Save Embed

;

All Cosmos Bio-Tech Holding EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$259 Mil.

All Cosmos Bio-Tech Holding (TPE:4148) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

All Cosmos Bio-Tech Holding's annualized ROC % for the quarter that ended in Dec. 2024 is calculated as:

	ROC % (Q: Dec. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Sep. 2024 )	+	Invested Capital (Q: Dec. 2024 ))	/ count )
=	179.092 * ( 1 - 39.06% )	/	( (2354.056	+	2188.835)	/ 2 )
=	109.1386648	/	2271.4455
=	4.80 %

where

	Invested Capital		(Q: Sep. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3843.291	-	253.217	-	( 1236.018	-	max(0, 506.787	-	2793.952	+	1236.018	))
=	2354.056

	Invested Capital		(Q: Dec. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3670.574	-	232.059	-	( 1249.68	-	max(0, 478.749	-	2661.24	+	1249.68	))
=	2188.835

Note: The Operating Income data used here is four times the quarterly (Dec. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

All Cosmos Bio-Tech Holding's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Sep. 2024		Q: Dec. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	219.032	/	( ( (963.235 + max(1285.907, 0))	+	(937.885 + max(1172.097, 0)) )	/	2 )
=	219.032	/	( ( 2249.142	+	2109.982 )	/	2 )
=	219.032	/	2179.562
=	10.05 %

where Working Capital is:

	Working Capital		(Q: Sep. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(620.822	+	804.142	+	121.647)	-	(253.217	+	0	+	7.487)
=	1285.907

	Working Capital		(Q: Dec. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(618.723	+	675.032	+	113.453)	-	(232.059	+	0	+	3.052)
=	1172.097

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

All Cosmos Bio-Tech Holding's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2024 )
	=	258.853	/	2297.218
	=	11.27 %

All Cosmos Bio-Tech Holding EBIT Related Terms

Thank you for viewing the detailed overview of All Cosmos Bio-Tech Holding's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

All Cosmos Bio-Tech Holding Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » All Cosmos Bio-Tech Holding Corp (TPE:4148) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

PLO 650, Jalan Keluli 7, Pasir Gudang Industrial Estate, Johor Bahru, JHR, MYS, 81700

Website

https://www.allcosmos.com

All Cosmos Bio-Tech Holding Corp focuses on the production and sale of Bio-organic and Bio-chemical compound fertilizers. The products are also exported to Taiwan, Indonesia, Vietnam, China, Cambodia, and the Philippines. Its segments are All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others. It generates the majority of its revenue from All Cosmos Industries Sdn. Bhd. (ACI). It operates mainly in Malaysia.

All Cosmos Bio-Tech Holding Headlines

No Headlines